Form 4 for CGNX COGNEX CORP
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001829813-25-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-24 | 2025-02-20+ | CGNX | Moschner Matthew | Pres, COO | F - Tax | $33.01 | -1,866 | 1,325 | -58% | -$61.6K |
| DM | 2025-02-24 | 2025-02-20+ | CGNX | Moschner Matthew | Pres, COO | M - OptEx | $0.00 | +5,678 | 2,029 | New | $0 |
| DM | 2025-02-24 | 2025-02-20+ | CGNX | Moschner Matthew | Pres, COO | M - OptEx | $0.00 | -5,678 | 3,495 | -62% | $0 |
| D | 2025-02-24 | 2025-02-21 | CGNX | Moschner Matthew | Pres, COO | A - Grant | $0.00 | +76.9K | 76.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-22 | F | D | 452 | $32.78 | 3,812 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-22 | M | A | 1,552 | $0.00 | 4,264 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-21 | F | D | 710 | $32.78 | 2,712 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-21 | M | A | 2,097 | $0.00 | 3,422 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-20 | F | D | 704 | $33.40 | 1,325 | D | — | — | |
| 6 | Common | Common Stock | 2025-02-20 | M | A | 2,029 | $0.00 | 2,029 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2025-02-22 | M | D | 1,552 | $0.00 | 0 | D | $0.00 · 2023-02-22 to 2025-02-22 | 1,552 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. (F6) The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-02-21 | A | A | 76,924 | $0.00 | 76,924 | D | $32.78 · 2029-02-21 to 2035-02-21 | 76,924 Common Stock | (F4) The options vest approximately 50% on the fourth anniversary of the grant date (February 21, 2025) and 50% on the fifth anniversary of the grant date. |
| 9 | Derivative | Restricted Stock Unit | 2025-02-20 | M | D | 2,029 | $0.00 | 8,113 | D | $0.00 · 2025-02-20 to 2027-02-20 | 2,029 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. (F8) The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively. |
| 10 | Derivative | Restricted Stock Unit | 2025-02-21 | M | D | 2,097 | $0.00 | 3,495 | D | $0.00 · 2024-02-21 to 2026-02-21 | 2,097 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. (F7) The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. |